1. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, P. Walter. Molecular biology of the cell, 4th edn. (Garland Science/The Lipid Bilayer, New York, 2002).
https://www.ncbi.nlm.nih.gov/books/NBK26871/
2. A.R. Annamalai, R. Manavalan, Effects of Trikatu and its individual components and piperine on gastrointestinal tracts: Trikatu a bioavailable enhancer. Ind. Drugs 27(12), 595–604 (1989)
3. C.K. Atal, R.K. Dubey, J. Singh, Biochemical basis of enhanced drug bioavailability by piperine: Evidence that piperine is a potent inhibitor of drug metabolism. J. Pharmacol. Exp. Therap. 232, 258–262 (1985)
4. S.I.F. Badawy, M.M. Ghorab, C.M. Adeyeye, Characterization and bioavailability of danazolhydroxypropyl-β-cyclodextrin coprecipitates. Int. J. Pharm. 128(1–2), 45–54 (1996)
5. S. Bajad, K.S. Bedi, A.K. Singla, R.K. Johri, Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice. Planta Med. 67, 176–179 (2001)